Rheumatology Chronic Care Risk Stratification Workflow
Optimize rheumatology patient outcomes with a risk stratification workflow focused on biologic monitoring, RA flare management, and APCM enrollment.
Effective rheumatology care requires more than quarterly visits; it demands a proactive risk stratification model. By categorizing patients based on disease activity scores like CDAI or RAPID3 and medication complexity, practices can ensure that high-risk patients on biologics receive the intensive monitoring required while stable patients maintain adherence through automated touchpoints.
Manual risk assessment in rheumatology is often reactive, leading to missed lab windows for biologics, delayed flare interventions, and administrative bottlenecks that extend wait times for high-acuity lupus or RA patients who need immediate care.
Step-by-Step Workflow
Biologic and DMARD Inventory Mapping
Identify all patients currently prescribed biologic or targeted synthetic DMARDs. These patients require high-frequency monitoring for hepatotoxicity, cytopenias, and latent infection reactivation as per ACR guidelines and REMS programs.
- Cross-reference specialty pharmacy records with EMR data
- Flag patients on dual immunosuppression
- Failing to update the medication list after a specialty pharmacy switch
Clinical Activity Score Tiering
Categorize patients into high, moderate, or low risk tiers based on their most recent Clinical Disease Activity Index (CDAI) or SLEDAI scores. High-activity patients should be prioritized for monthly APCM check-ins.
- Use RAPID3 scores for a quick patient-reported assessment
- Update tiers every 3 to 6 months
- Relying solely on subjective patient reports without standardized scoring
Automated Lab Compliance Monitoring
Deploy AI-powered call handling to contact patients 7 days before their scheduled biologic labs. This ensures that lab results are available for the physician to review before the next infusion or prescription refill.
- Sync AI outreach with the practice's lab interface
- Provide patients with localized lab options to increase compliance
- Waiting until the patient's appointment to realize labs are missing
Flare History and Steroid Dependency Review
Analyze EMR data to identify 'brittle' patients who have required more than two prednisone bursts or urgent steroid injections in the last 12 months. These patients represent the highest risk for long-term complications.
- Track steroid taper success rates
- Prioritize these patients for biologic therapy escalation discussions
- Overlooking cumulative steroid dose as a risk factor
Comorbidity and Extramanifestation Screening
Identify patients with systemic involvements such as interstitial lung disease (ILD) or cardiovascular risk factors. Stratify these patients for multidisciplinary coordination with pulmonology or cardiology.
- Use a standardized checklist for extra-articular manifestations
- Automate referrals for annual eye exams for patients on hydroxychloroquine
- Treating joint symptoms while ignoring systemic inflammation indicators
Principal Care Management (APCM) Enrollment
Formalize the stratification by enrolling eligible patients into an APCM program. Use AI to handle the monthly 20-minute non-face-to-face requirements, focusing on medication adherence and flare detection.
- Ensure documentation meets CMS requirements for APCM billing
- Focus AI scripts on morning stiffness and joint swelling duration
- Inconsistent documentation leading to lost APCM revenue
Expected Outcomes
95% compliance rate for required biologic monitoring labs
Significant reduction in emergency 'fit-in' appointments through proactive flare management
Increased practice revenue through systematic APCM and CCM enrollment
Improved patient satisfaction scores due to responsive communication between visits
Better long-term outcomes through tighter control of systemic inflammation
Frequently Asked Questions
AI call systems can automatically identify patients whose lab windows are approaching, call them to provide reminders, and even help schedule the lab appointment, ensuring results are ready for physician review.
Yes, by maintaining accurate disease activity scores (CDAI/RAPID3) through regular automated check-ins, you have the longitudinal data required by payers to justify biologic therapy or switches.
AI-powered call handling can triage flare calls using a clinical protocol, determining if the patient needs an urgent steroid burst, a lab order, or an expedited in-office visit based on their risk tier.
It can be manual, but using an automated system to track monthly patient touchpoints regarding their single high-risk chronic condition (like RA or Lupus) simplifies the billing process for 99424 and 99426 codes.
Ready to transform your rheumatology practice?
See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.
Schedule a Demo